Rational use of mucoactive medications to treat pediatric airway disease

Many airway diseases in children, notably bronchiolitis, cystic fibrosis (CF), non-CF bronchiectasis including primary ciliary dyskinesia, pneumonia, and severe asthma are associated with retention of airway secretions. Medications to improve secretions clearance, the mucoactive medications, are emp...

Descripción completa

Detalles Bibliográficos
Autores principales: Linssen, R.S.N., Ma, J., Bem, R.A., Rubin, B.K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2020
Materias:
Mini-symposium: Diagnosis and management of pulmonary lymphatic disorders
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7297155/
https://www.ncbi.nlm.nih.gov/pubmed/32653467
http://dx.doi.org/10.1016/j.prrv.2020.06.007
_version_ 1783546953826566144
author Linssen, R.S.N.
Ma, J.
Bem, R.A.
Rubin, B.K.
author_facet Linssen, R.S.N.
Ma, J.
Bem, R.A.
Rubin, B.K.
author_sort Linssen, R.S.N.
collection PubMed
description Many airway diseases in children, notably bronchiolitis, cystic fibrosis (CF), non-CF bronchiectasis including primary ciliary dyskinesia, pneumonia, and severe asthma are associated with retention of airway secretions. Medications to improve secretions clearance, the mucoactive medications, are employed to treat these diseases with varying degrees of success. This manuscript reviews evidence for the use of these medications and future directions of study.
format Online
Article
Text
id pubmed-7297155
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Elsevier Ltd.
record_format MEDLINE/PubMed
spelling pubmed-72971552020-06-17 Rational use of mucoactive medications to treat pediatric airway disease Linssen, R.S.N. Ma, J. Bem, R.A. Rubin, B.K. Paediatr Respir Rev Mini-symposium: Diagnosis and management of pulmonary lymphatic disorders Many airway diseases in children, notably bronchiolitis, cystic fibrosis (CF), non-CF bronchiectasis including primary ciliary dyskinesia, pneumonia, and severe asthma are associated with retention of airway secretions. Medications to improve secretions clearance, the mucoactive medications, are employed to treat these diseases with varying degrees of success. This manuscript reviews evidence for the use of these medications and future directions of study. Elsevier Ltd. 2020-11 2020-06-16 /pmc/articles/PMC7297155/ /pubmed/32653467 http://dx.doi.org/10.1016/j.prrv.2020.06.007 Text en © 2020 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Mini-symposium: Diagnosis and management of pulmonary lymphatic disorders
Linssen, R.S.N.
Ma, J.
Bem, R.A.
Rubin, B.K.
Rational use of mucoactive medications to treat pediatric airway disease
title Rational use of mucoactive medications to treat pediatric airway disease
title_full Rational use of mucoactive medications to treat pediatric airway disease
title_fullStr Rational use of mucoactive medications to treat pediatric airway disease
title_full_unstemmed Rational use of mucoactive medications to treat pediatric airway disease
title_short Rational use of mucoactive medications to treat pediatric airway disease
title_sort rational use of mucoactive medications to treat pediatric airway disease
topic Mini-symposium: Diagnosis and management of pulmonary lymphatic disorders
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7297155/
https://www.ncbi.nlm.nih.gov/pubmed/32653467
http://dx.doi.org/10.1016/j.prrv.2020.06.007
work_keys_str_mv AT linssenrsn rationaluseofmucoactivemedicationstotreatpediatricairwaydisease
AT maj rationaluseofmucoactivemedicationstotreatpediatricairwaydisease
AT bemra rationaluseofmucoactivemedicationstotreatpediatricairwaydisease
AT rubinbk rationaluseofmucoactivemedicationstotreatpediatricairwaydisease

Ejemplares similares